Colitis increases the risk of
colorectal cancer; however, the mechanism of the association between
colitis and
cancer remains largely unknown. To identify
colitis-associated cancer promoting factors, we investigated gene expression changes caused by
dextran sulfate sodium (DSS)-induced
colitis in mice. By analyzing gene expression profiles, we found that
IL11 was upregulated in DSS-induced
colitis tissue and 2-amino-1-methyl-6-phenylimidazo[4,5-
b]-pyridine (
PhIP)/DSS-induced colon tumours in mice as well as in human
colorectal cancer. By characterizing the activation/phosphorylation of STAT3 (pSTAT3), we found that pSTAT3 was induced transiently in
colitis, but maintained at higher levels from hyper-proliferative dysplastic lesions to tumours. Using the
IL11 receptor (IL11Rα1) knockout mice, we found that pSTAT3 in the newly regenerated crypt epithelial cells in
colitis is abolished in IL11Rα1+/- and -/- mice, suggesting that
colitis-induced
IL11 activates STAT3 in colon crypt epithelial cells. Moreover,
colitis-promoted colon
carcinogenesis was significantly reduced in IL11Rα1+/- and -/- mice. To determine the roles of the
IL11 in
colitis, we found that the inhibition of
IL11 signalling by recombinant
IL11 antagonist mutein during
colitis was sufficient to attenuate
colitis-promoted
carcinogenesis. Together, our results demonstrated that
colitis-induced
IL11 plays critical roles in creating
cancer promoting microenvironment to facilitate the development of
colon cancer from dormant premalignant cells.